Adverse event profiles and time to onset and resolution with tremelimumab ( T) plus durvalumab (D) in patients with unresectable hepatocellular carcinoma (uHCC) in the phase 3 HIMALAYA trial Meeting Abstract
| Authors: | De Toni, E. M.; Sangro, B.; Chan, S. L.; Kudo, M.; Kelley, R. K.; K, K. Y.; Rimassa, L.; Varela, M.; Dayyani, F.; Makowsky, M.; Marcovitz, M.; McCoy, C. L.; Negro, A.; Abou-Alfa, G. |
| Abstract Title: | Adverse event profiles and time to onset and resolution with tremelimumab ( T) plus durvalumab (D) in patients with unresectable hepatocellular carcinoma (uHCC) in the phase 3 HIMALAYA trial |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (2023) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 46 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Oct 13-16 |
| Meeting Location: | Hamburg, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2023-10-01 |
| Start Page: | 239 |
| End Page: | 240 |
| Language: | English |
| ACCESSION: | WOS:001091456900523 |
| PROVIDER: | wos |
| PUBMED: | 37788643 |
| DOI: | 10.1159/000533576 |
| Notes: | Meeting Abstract: P688 -- Source: Wos |
